Intellectual Property
IP Financing in Light of SVB
It is not uncommon for companies to use their intellectual property (IP) as collateral to
Elisa Cooper
March 14, 2023
Insights. Ideas. Inspiration.Â
It is not uncommon for companies to use their intellectual property (IP) as collateral to
Public PAIR is the USPTO’s legacy patent tool. It is being replaced by the Patent
According to the latest announcement[1] from the Unified patent court (UPC) Agreement, there will be
New Release includes additional workflows, country rules, jurisdictions, and automated opt-out to support changes arising
When we talk of football, we can’t help but think of the FIFA World Cup,
To avoid the burden of challenging the validity of a granted European patent in the
Building a Team of IP Industry Leaders and Experts to Fill Market Void MaxVal Group,
Patent laws require an applicant to submit patent drawings whenever the invention can be explained
There is a myth within the IP world that maintaining intellectual property is the domain
This week’s newest patent applications are from AuraPea, Novartis, Medtronic, Roche, Boston Scientific, Novartis, Abbott,
This week’s newest patent applications from Midbar, Novartis, Abbott, Medtronic, Roche, Boston Scientific, Merck, Mastercard,
This week’s newest patent applications from Calvert, Novartis, Abbott, Roche, Merck, Medtronic, Boston Scientific, Visa,
Subscribe to Our Newsletter!
Sign-up for exclusive content and get the latest IP insights delivered directly to your inbox.